erythromycin stearate (CAS 643-22-1) — formula C37H67NO13.C18H36O2, molecular weight 1018.4; category pharmaceutical intermediates and APIs.
erythromycin stearate (CAS 643-22-1) is a chemical raw material in the pharmaceutical intermediates and APIs category. Its molecular formula C37H67NO13.C18H36O2 comprises 55 C, 103 H, 1 N, 15 O atoms. Its molecular weight is about 1018.4. Reported physicochemical data: melting point around 212 to 219 °F (NTP, 1992). As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.
| CAS Number | 643-22-1 |
|---|---|
| Molecular Formula | C37H67NO13.C18H36O2 |
| Molecular Weight | 1018.4 |
| Melting Point | 212 to 219 °F (NTP, 1992) |
| Applications | For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to <i>Corynebacterium diphtheriae</i>, in the treatment of infections due to <i>Corynebacterium minutissimum</i>, intestinal amebiasis caused by <i>Entamoeba histolytica</i>, acute pelvic inflammatory disease caused by <i>Neisseria gonorrhoeae</i> |
| Category | Pharmaceutical Intermediates & APIs |
Documented applications: For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to <i>Corynebacterium diphtheriae</i>, in the treatment of infections due to <i>Corynebacterium minutissimum</i>, intestinal amebiasis caused by <i>Entamoeba histolytica</i>, acute pelvic inflammatory disease caused by <i>Neisseria gonorrhoeae</i>.
erythromycin stearate is a pharmaceutical intermediate or API compound with CAS registry number 643-22-1 and molecular formula C37H67NO13.C18H36O2 (molecular weight 1018.4), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.
CAS number: 643-22-1
Its molecular formula C37H67NO13.C18H36O2 comprises 55 C, 103 H, 1 N, 15 O atoms.
Also known as: erythromycin stearate · 硬脂酸红霉素
Category: pharmaceutical intermediates and APIs
The CAS registry number of erythromycin stearate is 643-22-1.
Molecular formula C37H67NO13.C18H36O2, molecular weight 1018.4.
It is also registered under: erythromycin stearate, 硬脂酸红霉素.
Recorded applications: For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to <i>Corynebacterium diphtheriae</i>, in the treatment of infections due to <i>Corynebacterium minutissimum</i>, intestinal amebiasis caused by <i>Entamoeba histolytica</i>, acute pelvic inflammatory disease caused by <i>Neisseria gonorrhoeae</i>.
Category: Pharmaceutical Intermediates & APIs.
Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.
Independent reference data for erythromycin stearate (CAS 643-22-1), compiled from public chemistry databases.
| CAS Registry Number | 643-22-1 |
|---|---|
| PubChem CID | 12559 |
| Molecular formula | C37H67NO13.C18H36O2 |
| IUPAC name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid |
| UNII (FDA) | LXW024X05M |
| Molecular Weight | 1018.4 |
|---|---|
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 23 |
| Exact Mass | 1017.73277158 |
| Monoisotopic Mass | 1017.73277158 |
| Topological Polar Surface Area | 231 |
| Heavy Atom Count | 71 |
| Melting Point | 212 to 219 °F (NTP, 1992) |
|---|
ERYTHROMYCIN STEARATE; 643-22-1; Abboticine; Bristamycin; Gallimycin; Erypar; Dowmycin E; Wyamycin S; Pfizer-E; Eratrex; Ethril; Meberyt; Erythrocin stearate; Erythromycin octadecanoate (salt); Sk-erythromycin; Ethril 250
| GHS notification summary | 0.9% (1 / 106) |
|---|
| GHS notification summary | 0.9% (1 / 106) |
|---|---|
| Reported hazard statements | H317 (59.4%), H319 (39.6%), H334 (59.4%) |
This chemical does not meet GHS hazard criteria for 0.9% (1 of 106) of reports.
H317 (59.4%): May cause an allergic skin reaction [Warning Sensitization, Skin]
erythromycin stearate · CAS 643-22-1 · C37H67NO13.C18H36O2. UNII LXW024X05M. Melting Point: 212 to 219 °F (NTP, 1992).
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 硬脂酸红霉素